Atacand

C₃₃H₃₄N₆O₆610.70 g/mol

1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 2540.

Registration

Applicants: 1
Registrations: 3

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Equity Pharmaceutical (Pty) Ltd	Atacand	8 mg, 16 mg, 32 mg	320099, 320100, A390244	Not determined	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Atacand 8 MG EACH TABLET CONTAINS CANDESARTAN CILEXETIL 8,0 mg	8 mg	32009932/7.1.3/0099	Registered	Not determined	PI PIL
Atacand 16 MG EACH TABLET CONTAINS CANDESARTAN CILEXETIL 16 mg	16 mg	32010032/7.1.3/0100	Registered	Not determined	PI PIL
Atacand 32 MG EACH TABLET CONTAINS CANDESARTAN CILEXETIL 32,0 mg	32 mg	A390244A39/7.1.3/0244	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading Wikipedia summary

SAHPRA documents

Professional information (PI)For healthcare professionalsAtacand 8 MG, Equity Pharmaceutical (Pty) Ltd. SAHPRA's document for ATACAND Patient information leaflet (PIL)For patients and carersAtacand 8 MG, Equity Pharmaceutical (Pty) Ltd. SAHPRA's document for ATACAND

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles